Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clini...
Q2 2026
Aug 6, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Nov 6, 2025